A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

NCT06461208 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

DRUG: Encapsulated FMT
OTHER: Placebo

Sponsor

King's College London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]